Toni Celià-Terrassa

Highlights
•Immune pressure selects TIM3+ tumor cells during micrometastasis
•TIM3+ tumor cells exhibit stemness, EMT, and immune-evasive features
•TIM3 in tumor cells is a biomarker of poor prognosis
•(Neo)adjuvant TIM3 blockade prevents metastatic seeding and outgrowth

TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak Rozalén et al. report that TIM3 in breast cancer drives a specific mechanism of immune escape during micrometastasis. TIM3+ tumor cells exhibit stemness/EMT features and promote immune-evasion by indu...

We’re thrilled to share our latest publication in
@cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...

A fresh virtual event spotlighting cutting-edge immunotherapies => be at the forefront of innovation. Do not miss it!

🌟 The Beug foundation prize for Metastasis Research is now accepting applications for young leaders driving breakthroughs in the field. Don’t miss this wonderful chance and apply now for it: beugstiftung-metastase.de/apply-now/

Ya en Vigo con muchas ganas de conocer mejor la investigación del IISGS y presentar nuestros estudios en cáncer de mama, metástasis e inmunoterapias de mRNA.

Our AECC postdoctoral fellow Sandra Blasco wins the 1st talk award at the 11th FIT translational immunotherapy cancer conference. Congratulations and thanks to the organizers.

We are very excited to host Dr. Rosa Pascual MSCA fellow and support her outstanding career in breast cancer research!

Very proud of Catalina Rozalén for her amazing PhD thesis that she has defended today, and very grateful to the committe Roger Gomis, @casanova-acebes.bsky.social, and @alpcorreia.bsky.social for the great discussion. Congratulations Cati, very well desrved!

We are all mosaics Picture your body: It’s a collection of cells carrying thousands of genetic mistakes accrued over a lifetime — many harmless, some bad, and at least a few that may be good for you.

A nice article covering some of the surprises in the field of somatic mosaicism in the last decade. As I say there: "Judging by the discoveries that we are making at the moment, the journey has only just started. I expect many surprises in the next few years." knowablemagazine.org/content/arti...

Hello to my small Bsky community. We have postdoc positions open to study epigenetic mechanisms contributing to resistance to chemo+immuno in TNBC, and projects related to epigenetic determinants of neurodevelopmental disorders. Feel free to reach out to me here/via email. Please like and repost!

Feeling more than excited to host this Tuesday a fantastic speaker as @vickysanzmoreno.bsky.social in Barcelona @researchmar.bsky.social that will cover fascinating cellular biology in cancer metastasis. @icrlondon.bsky.social

10 days to #SABCS24. Excited to present at the conference the results of 4 studies, made possible by collaborations with brilliant Dana-Farber colleagues and with multiple external partners (RevealGenomics, Yale, Novartis). Come meet me at the posters on December 11th and 12th!

I'd like to join. Thanks for starting this group

What an achievement Anna👏 congrats to the team!

We should have the opportunity of hugging colleagues and friends more often!
@aseica.bsky.social
Awards:
- Achievements in Cancer Research. @joseptabernero.bsky.social
- Women in Science. Isabel Fabregat
- Social Impact. @ContraCancerEs